Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part I).
about
Effect of diabetes mellitus on mycophenolate sodium pharmacokinetics and inosine monophosphate dehydrogenase activity in stable kidney transplant recipientsConcentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism.Cefpiramide kinetics and plasma protein binding in cholestasis.Serum albumin concentrations: who needs them?Influence of overt diabetes mellitus on cyclosporine pharmacokinetics in a canine model.Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.Plasma lipoprotein distribution of liposomal nystatin is influenced by protein content of high-density lipoproteins.Developmental principles of antiepileptic drug therapy.Pharmacokinetics and safety of single intravenous infusions of the adenosine agonist, AMP 579, in patients with end-stage renal insufficiency.Lower plasma pantoprazole level predicts Helicobacter pylori treatment failure in patients with type 2 diabetes mellitus.Changes in the pharmacokinetic of sildenafil citrate in rats with Streptozotocin-induced diabetic nephropathy.Factors involved in the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer: clinical and experimental studies.
P2860
Q33849526-9929DC4D-8937-4AF4-8896-44AC20F9A94AQ33977228-01DE7B51-16E5-484D-A239-8422093DF5DAQ34346158-BF85CF95-8F78-4B3D-81A2-92857D2A9F07Q35466732-5628E82A-859A-4004-BFB8-FCD12FF545B7Q37393359-5BB0E594-F1EC-4D73-956D-BE30FAF372B8Q38016232-C1D05C52-04A1-49AD-8646-6D39B2900B89Q39558179-42ABAF0C-9D55-4DEB-9F31-3EFA7EEAE069Q40570295-55C203BF-86CD-41C2-BBC5-3E2E7C1802ECQ40758319-65D7A8AE-17D7-4AAE-8CFE-65B1FA4DD829Q41121037-EC0CC77D-E061-46A4-825F-699F663FF552Q41951810-604AEBB9-7B59-4E89-9FA8-803041A7C900Q44601143-66F2DCF1-DA91-4189-91C5-6B1C5E0C1780
P2860
Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part I).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Disease-induced variations in ...... drug dosage regimens (Part I).
@en
type
label
Disease-induced variations in ...... drug dosage regimens (Part I).
@en
prefLabel
Disease-induced variations in ...... drug dosage regimens (Part I).
@en
P2093
P1476
Disease-induced variations in ...... drug dosage regimens (Part I).
@en
P2093
P304
P356
10.2165/00003088-199019020-00004
P577
1990-08-01T00:00:00Z
P6179
1049551499